USPTO Alert – New fast track for certain COVID-19 trademark applications

The United States Patent & Trademark Office (“USPTO”) announces a new prioritized trademark examination program for certain trademark applications covering COVID-19 related products and services. The program is part of the USPTO’s push to support innovation during the COVID-19 pandemic and bring life-saving treatments and research to market more quickly.

Index

The USPTO has announced a new expedited review pathway for trademark applications covering certain COVID-19-related goods and services. The new process will fast track these trademark applications to shave off roughly two months of the USPTO examination timeline.

Eligible applications are those covering one or more of the following qualifying COVID-19 medical goods or services:

  • Pharmaceutical products or medical devices such as diagnostic tests, ventilators, and personal protective equipment, including surgical masks, face shields, gowns, and gloves, that prevent, diagnose, treat, or cure COVID-19 and are subject to approval by the United States Food and Drug Administrations; and
  • Medical services or medical research services for the prevention, diagnosis, treatment of, or cure for COVID-19.


The approvals referenced above include, but are not limited to, Investigational New Drug (IND) applications, Investigational Device Exemptions (IDE), New Drug Applications (NDA), Biologics License Applications (BLA), Premarket Approvals (PMA), or Emergency Use Authorizations (EUA).

To request this expedited treatment, an applicant must first file the trademark application itself and then file a Petition to the Director identifying the newly assigned serial number for the application. The USPTO has waived the government fee to request expedited examination, but the usual trademark filing fees still apply.


Applicants may also take additional affirmative steps to expedite examination by responding promptly to office actions, emails, and phone calls from the USPTO. Overall, the new process makes it possible to obtain a trademark registration in four-to-six months rather than the traditional six-to-eight months (if that, under best circumstances).

 

Next steps

If your business is developing or offering COVID-19-related products or services, and you wish to protect these innovative and important treatments through trademark registrations, please contact Anna Kurian Shaw and Brendan C. Quinn.

 

Authored by Anna Kurian Shaw and Brendan C. Quinn

 

Contacts
Anna Shaw
Partner
Washington, D.C.
Brendan Quinn
Senior Associate
Washington, D.C.
Index

 

This website is operated by Hogan Lovells International LLP, whose registered office is at Atlantic House, Holborn Viaduct, London, EC1A 2FG. For further details of Hogan Lovells International LLP and the international legal practice that comprises Hogan Lovells International LLP, Hogan Lovells US LLP and their affiliated businesses ("Hogan Lovells"), please see our Legal Notices page. © 2024 Hogan Lovells.

Attorney advertising. Prior results do not guarantee a similar outcome.